2Seventy Bio Analysis
| TSVTDelisted Stock | USD 5.00 0.00 0.00% |
2Seventy Bio holds a debt-to-equity ratio of 0.73. 2Seventy Bio's financial risk is the risk to 2Seventy Bio stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
2Seventy Bio's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. 2Seventy Bio's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps 2Seventy Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect 2Seventy Bio's stakeholders.
For many companies, including 2Seventy Bio, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for 2Seventy Bio, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, 2Seventy Bio's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that 2Seventy Bio's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which 2Seventy Bio is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of 2Seventy Bio to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, 2Seventy Bio is said to be less leveraged. If creditors hold a majority of 2Seventy Bio's assets, the Company is said to be highly leveraged.
2Seventy Bio is overvalued with Real Value of 3.71 and Hype Value of 5.0. The main objective of 2Seventy Bio delisted stock analysis is to determine its intrinsic value, which is an estimate of what 2Seventy Bio is worth, separate from its market price. There are two main types of 2Seventy Bio's stock analysis: fundamental analysis and technical analysis.
The 2Seventy Bio stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. 2Seventy Bio is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. 2Seventy Stock trading window is adjusted to America/New York timezone.
2Seventy |
2Seventy Stock Analysis Notes
About 82.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.24. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. 2Seventy Bio recorded a loss per share of 0.08. The entity had not issued any dividends in recent years. 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts. 2Seventy Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 437 people. To find out more about 2Seventy Bio contact the company at 617 675 7270 or learn more at https://www.2seventybio.com.2Seventy Bio Investment Alerts
| 2Seventy Bio is not yet fully synchronised with the market data | |
| 2Seventy Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 37.86 M. Net Loss for the year was (57.25 M) with loss before overhead, payroll, taxes, and interest of (13.24 M). | |
| 2Seventy Bio currently holds about 357.93 M in cash with (85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 82.0% of the company shares are owned by institutional investors |
2Seventy Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 266.14 M.2Seventy Profitablity
The company has Profit Margin (PM) of (0.08) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.11) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.11.2Seventy Bio Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific 2Seventy Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on 2Seventy Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases 2Seventy Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
2Seventy Bio Outstanding Bonds
2Seventy Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. 2Seventy Bio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most 2Seventy bonds can be classified according to their maturity, which is the date when 2Seventy Bio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US90138FAC68 Corp BondUS90138FAC68 | View | |
| US90138FAD42 Corp BondUS90138FAD42 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
2Seventy Bio Predictive Daily Indicators
2Seventy Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of 2Seventy Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
2Seventy Bio Debt to Cash Allocation
2Seventy Bio currently holds 243.72 M in liabilities with Debt to Equity (D/E) ratio of 0.73, which is about average as compared to similar companies. 2Seventy Bio has a current ratio of 3.8, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about 2Seventy Bio's use of debt, we should always consider it together with its cash and equity.2Seventy Bio Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the 2Seventy Bio's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of 2Seventy Bio, which in turn will lower the firm's financial flexibility.2Seventy Bio Corporate Bonds Issued
About 2Seventy Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how 2Seventy Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling 2Seventy shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as 2Seventy Bio. By using and applying 2Seventy Stock analysis, traders can create a robust methodology for identifying 2Seventy entry and exit points for their positions.
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts. 2Seventy Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 437 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding 2Seventy Bio to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
| All Next | Launch Module |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in 2Seventy Stock
If you are still planning to invest in 2Seventy Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the 2Seventy Bio's history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |